Personalized Evidence-based Medicine
Heath care providers and payers have more information than ever before to direct patient care. The evolution of biomedical information provides greater volume and granularity of patient data at every step.
Initially, practitioners had to rely on clinical data only. Next was the use of a microscope as a discovery tool. As time progressed, genetic markers were discovered that are indicators of predisposition to disease or therapy efficacy. A major breakthrough occurred when the human genome was mapped and data even at the single nucleotide level became available to practitioners.
However, this breakthrough was a double-edged sword. On one side, you have the opportunity to understand human health, disease, therapy, and outcomes at a most granular level. On the other, you have more information than a human can possibly process – 24 chromosomes support over 30,000 genes with millions of single nucleotide polymorphisms (SNPs). With conventional tools, it is impossible to understand the relationships of the genes to genes, SNPs to SNPs, genes to SNPs, including other clinical information, and how these instructions guide the progression of health, disease and outcomes.
Saffron’s ExtremeIntelligence™ platformenables health care providers to analyze and understand genomics to better diagnose, treat, and predict outcomes for patients. Using ExtremeIntelligence™memory-based entity analytics and prediction, genomic information from patients can be compared to historical genomic information from a massive population of patients to classify them, using the taxonomy resident in the data, to groups with known therapies and outcomes. This information can then be used to provide efficient, cost effective, patient care accelerating the time to effective and efficient treatment, and improving quality of life.
Saffron ExtremeIntelligence™ Unleashing your Brainpower